Fri.Jul 26, 2024

article thumbnail

The FDA Approves Deuruxolitinib for Severe Alopecia in Adults

Dermatology Times

Along with the approval, Sun Pharma is introducing an access program to assist eligible patients in starting and adhering to the treatment.

article thumbnail

Olaplex Launch Inspires Curl Confidence: NEW Patented OLAPLEX Bond Shaping Technology 

Salon Today

The product offerings were specifically created to support natural curl patterns and textures and represents revolutionary curl innovation in-salon and at home.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Emerging Therapeutic for Non-Segmental Vitiligo: Merck’s MK-6194

Dermatology Times

Iltefat Hamzavi, MD, discusses the REGINA 007 phase 2 trial evaluating MK-6194 for the treatment of non-segmental vitiligo.

article thumbnail

Learn How the Power of Numbers Can Amplify Harmony and Prosperity

Salon Today

Jesse Kalsi transforms lives with his timeless wisdom about astronumerology and his groundbreaking method of number patching. His book empowers readers to manifest successful futures by harmonizing the energy in their lives using house numbers, birth dates, addresses, name numbers and more.

59
article thumbnail

1

Mindbody

This month’s product updates include appointment optimizations, easy-to-sync branded web widgets, and more—changes that can help make the most of your software.

article thumbnail

Electroablation Plus Pharmacotherapy Leads to Reduction in Keloid Volume

Dermatology Times

Combining electrocoagulation with pharmacotherapy significantly reduced keloid scar volume by inhibiting collagen deposition, angiogenesis, and cell proliferation.

More Trending

article thumbnail

The Weekly Roundup: July 22-26

Dermatology Times

In case you missed it, this week we had news about the FDA approval of deuruxolitinib for severe alopecia in adults, new nonmelanoma guidelines from the Dermatology Association of Radiation Therapy, Arcutis' submitted sNDA for roflumilast foam for scalp and body psoriasis, and more.

Therapy 41
article thumbnail

MY SALON Suite Boosts Beauty Industry with Scholarship Opportunities for Students

Beauty Launchpad

MY SALON Suite announced it is offering 10 new $1,000 scholarship opportunities to help aspiring salon professionals achieve a license in cosmetology, barbering, esthetics, nail technology or massage therapy

Salon 40
article thumbnail

Complex Relationship Between Air Pollutants and Secondary Sensitive Skin in Patients With Acne

Dermatology Times

Investigators looked into pollutant-induced disruption of the skin barrier, increased transepidermal water loss, and heightened inflammatory responses.

article thumbnail

FDA Accepts BLA Resubmission of Cosibelimab for the Treatment of Advanced cSCC

The Dermatology Digest

The U.S. Food and Drug Administration (FDA) has accepted for review Checkpoint’s resubmission of its Biologics License Application (BLA) for cosibelimab, its anti-programmed death ligand-1 (PD-L1) antibody, as a potential new treatment for adults with metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) who are not candidates for curative surgery or curative radiation.

article thumbnail

Study Highlights Efficacy of Lotion with Biotechnological Phytocomplex, Niacinamide, and Succinic Acid in Enhancing Microbiota Diversity and Reducing Acne Severity

Dermatology Times

The lotion effectively rebalanced the microbiota, reduced erythema and desquamation, and improved acne severity.

41
article thumbnail

Social Media and Psoriasis: Addressing Misinformation on TikTok

Dermatology Times

A recent study found psoriasis content deemed “unreliable” still obtained 850,000 likes.